News

Showing 441 - 450 out of 941 results

Resource

Saint Luke’s and UMKC to Lead Nationwide Study on Pregnant People with Heart Conditions in Effort to Help Combat Maternal Morbidity, Mortality

NIH awards more than $7.9 million grant to Healthcare Institute for Innovations in Quality

Kansas City Business Journal: These 20 Health Care Professionals Keep KC's Pulse Humming

The Kansas City Business Journal named Bobby Olm-Shipman, CEO of Saint Luke's South and East Region, as one of its 20 health care professionals to know in the Kansas City area for 2024.

Article

Wife Saves Husband's Life with CPR, Now Advocates for Community Education

Mariah has made it her mission to spread the important message that everyone should know CPR as it could save a loved one's life.

News

JAMA Medical News: Even After CPR, Surviving Out-of-Hospital Cardiac Arrest Might Be Influenced by Race, Sex

A new study provides evidence that even among those who receive CPR, Black or female individuals are less likely to survive an out-of-hospital cardiac arrest than White or male individuals.

Article

KSHB: New Ruling Says Patients Must Be Notified of Breast Density After a Mammogram

Dr. Mary Mitchell, chief of breast radiology at Saint Luke's, talks to KSHB about what dense breast tissue is and how it impacts your risk of developing breast cancer.

Article

TIME: Is Tennis Really the 'World's Healthiest Sport'? We Fact-Checked the Claim

TIME talked to Dr. James O'Keefe about research that found tennis can positively impact a person's longevity.

Research

Times Radio: Research Finds New Positive Impacts of Semaglutide

More than 10 studies presented at the European Society of Cardiology Congress revealed new findings on the far-reaching benefits of semaglutide.

News

BBC News: Studies Reveal New Effects of Semaglutide

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

Article

American Journal of Managed Care: Semaglutide Enhances Heart Failure Outcomes in Obesity

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

Research

Pharmaceutical Technology: ESC 2024: Obesity Drugs Emerge as Attractive Tool for Heart Failure Prevention

Cardiology experts discussed the relationship between obesity and heart failure while referencing new clinical trial results at the ESC 2024 Congress.